首页> 外国专利> Stem cell having improved hypoxia adaptation and therapeutic potential by induction of BICD1 expression and method for preparing the same, and cell therapeutic composition comprising the same

Stem cell having improved hypoxia adaptation and therapeutic potential by induction of BICD1 expression and method for preparing the same, and cell therapeutic composition comprising the same

机译:通过诱导BICD1表达及其制备方法,具有改善的缺氧适应和治疗潜力的干细胞和包含相同的细胞治疗组合物

摘要

The present invention relates to stem cells with improved ischemic adaptation ability and therapeutic function through increased expression of BICD1 (Bicaudal D homolog 1); Cell therapy composition for the prevention or treatment of ischemic diseases, containing the stem cells or cells differentiated from the mesenchymal stem cells as an active ingredient; And it relates to a method for producing stem cells with improved therapeutic function in hypoxic conditions, characterized in that it comprises the step of increasing the expression of BICD1. It is significant in that it suggests a new approach to control ischemic adaptation, and it can significantly increase the effectiveness of mesenchymal stem cells in therapeutic application, and will be widely used in fields such as medicine, pharmaceuticals, and veterinary medicine. can
机译:本发明涉及具有改善缺血适应能力和治疗功能的干细胞通过增加BICD1的表达(BicaudaL D同性恋1); 用于预防或治疗缺血性疾病的细胞疗法组合物,含有从间充质干细胞分化为活性成分的干细胞; 并且涉及一种在缺氧条件下产生具有改善的治疗功能的干细胞的方法,其特征在于它包括增加BICD1的表达的步骤。 重要的是,它表明一种新方法可以控制缺血性适应,并且可以显着提高间充质干细胞在治疗应用中的有效性,并且将广泛用于药物,药品和兽医等领域。 能够

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号